How Do GLP-1 Agents Factor Into Neuroendocrine Tumor Care Strategies?ByJoseph Dillon, MB, BCh, BAONovember 5th 2025In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.